Schytte T, Hansen O, Stolberg-Rohr T, Brink C. Cardiac toxicity and radiation dose to the heart in definitive treated non-small cell lung cancer. Acta Oncol. 2010;49:1058–60. https://doi.org/10.3109/0284186X.2010.504736

Article  PubMed  Google Scholar 

Han CB, Wang WL, Quint L, Xue JX, Matuszak M, Ten Haken R, et al. Pulmonary artery invasion, high dose radiation, and overall survival in patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014;89:313 https://doi.org/10.1016/J.IJROBP.2014.02.011

Article  PubMed  PubMed Central  Google Scholar 

Tucker SL, Liu A, Gomez D, Tang LL, Allen P, Yang J, et al. Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation. Radiother Oncol. 2016;119:495–500. https://doi.org/10.1016/J.RADONC.2016.04.025

Article  PubMed  Google Scholar 

Speirs CK, DeWees TA, Rehman S, Molotievschi A, Velez MA, Mullen D, et al. Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer. J Thorac Oncol.2017;12:293–301. https://doi.org/10.1016/J.JTHO.2016.09.134

Article  PubMed  Google Scholar 

Vivekanandan S, Landau DB, Counsell N, Warren DR, Khwanda A, Rosen SD, et al. The impact of cardiac radiation dosimetry on survival after radiation therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;99:51–60. https://doi.org/10.1016/j.ijrobp.2017.04.026

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dess RT, Sun Y, Matuszak MM, Sun G, Soni PD, Bazzi L, et al. Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer. J Clin Oncol. 2017;35:1395–402. https://doi.org/10.1200/JCO.2016.71.6142

Article  PubMed  PubMed Central  Google Scholar 

Wang K, Eblan MJ, Deal AM, Lipner M, Zagar TM, Wang Y, et al. Cardiac toxicity after radiotherapy for stage iii non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy. J Clin Oncol. 2017;35:1387–94. https://doi.org/10.1200/JCO.2016.70.0229

Article  PubMed  PubMed Central  Google Scholar 

Wang K, Pearlstein KA, Patchett ND, Deal AM, Mavroidis P, Jensen BC, et al. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer. Radiother Oncol. 2017;125:293–300. https://doi.org/10.1016/J.RADONC.2017.10.001

Article  PubMed  PubMed Central  Google Scholar 

Johnson MD, Sura K, Mangona VS, Glick A, Wallace M, Ye H, et al. Matched-pair analysis of high dose versus standard dose definitive chemoradiation for locally advanced non–small-cell lung cancer. Clin Lung Cancer. 2017;18:149–55. https://doi.org/10.1016/J.CLLC.2016.06.004

Article  PubMed  CAS  Google Scholar 

Ma JT, Sun L, Sun X, Xiong ZC, Liu Y, Zhang SL, et al. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy. Radiat Oncol. 2017;12:1–10. https://doi.org/10.1186/S13014-017-0772-5/FIGURES/4

Article  Google Scholar 

Stam B, van der Bijl E, van Diessen J, Rossi MMG, Tijhuis A, Belderbos JSA, et al. Heart dose associated with overall survival in locally advanced NSCLC patients treated with hypofractionated chemoradiotherapy. Radiother Oncol. 2017;125:62–5. https://doi.org/10.1016/J.RADONC.2017.09.004

Article  PubMed  Google Scholar 

Guberina M, Eberhardt W, Stuschke M, Gauler T, Heinzelmann F, Cheufou D, et al. Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial. Ann Oncol. 2017;28:1084–9. https://doi.org/10.1093/ANNONC/MDX069

Article  PubMed  CAS  Google Scholar 

McWilliam A, Kennedy J, Hodgson C, Vasquez Osorio E, Faivre-Finn C, van Herk M. Radiation dose to heart base linked with poorer survival in lung cancer patients. Eur J Cancer. 2017;85:106–13. https://doi.org/10.1016/J.EJCA.2017.07.053

Article  PubMed  Google Scholar 

Yegya-Raman N, Wang K, Kim S, Reyhan M, Deek MP, Sayan M, et al. Dosimetric predictors of symptomatic cardiac events after conventional-dose chemoradiation therapy for inoperable NSCLC. J Thorac Oncol. 2018;13:1508–18. https://doi.org/10.1016/J.JTHO.2018.05.028

Article  PubMed  PubMed Central  Google Scholar 

Lee CC, Zheng H, Soon YY, Foo LL, Koh WY, Leong CN, et al. Association between radiation heart dosimetric parameters, myocardial infarct and overall survival in stage 3 non-small cell lung cancer treated with definitive thoracic radiotherapy. Lung Cancer. 2018;120:54–9. https://doi.org/10.1016/J.LUNGCAN.2018.03.024

Article  PubMed  Google Scholar 

Lee CC, Chua GWY, Zheng H, Soon YY, Foo LL, Thiagarajan A, et al. Are heart doses associated with survival in patients with non-small cell lung cancer who received post-operative thoracic radiotherapy?: A national population-based study. Medicine. 2019;98:e17020. https://doi.org/10.1097/MD.0000000000017020

Article  PubMed  PubMed Central  CAS  Google Scholar 

Borkenhagen JF, Bergom C, Rapp CT, Klawikowski SJ, Rein LE, Gore EM. Dosimetric predictors of cardiotoxicity in thoracic radiotherapy for lung cancer. Clin Lung Cancer. 2019;20:435–41. https://doi.org/10.1016/J.CLLC.2019.05.014

Article  PubMed  Google Scholar 

Atkins KM, Rawal B, Chaunzwa TL, Lamba N, Bitterman DS, Williams CL, et al. Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer. J Am Coll Cardiol. J Am Coll Cardiol. 2019;73:2976–87. https://doi.org/10.1016/J.JACC.2019.03.500

Article  PubMed  Google Scholar 

Hotca A, Thor M, Deasy JO, Rimner A. Dose to the cardio-pulmonary system and treatment-induced electrocardiogram abnormalities in locally advanced non-small cell lung cancer. Clin Transl Radiat Oncol. 2019;19:96. https://doi.org/10.1016/J.CTRO.2019.09.003

Article  PubMed  PubMed Central  Google Scholar 

McWilliam A, Khalifa J, Vasquez Osorio E, Banfill K, Abravan A, Faivre-Finn C, et al. Novel methodology to investigate the effect of radiation dose to heart substructures on overall survival. Int J Radiat Oncol Biol Phys. 2020;108:1073–81. https://doi.org/10.1016/J.IJROBP.2020.06.031

Article  PubMed  Google Scholar 

McWilliam A, Dootson C, Graham L, Banfill K, Abravan A, van Herk M. Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy. Phys Imaging Radiat Oncol. 2020;15:46–51. https://doi.org/10.1016/J.PHRO.2020.07.002

Article  PubMed  PubMed Central  Google Scholar 

Thor M, Deasy JO, Hu C, Gore E, Bar-Ad V, Robinson C. et al.Modeling the impact of cardiopulmonary irradiation on overall survival in NRG oncology trial RTOG 0617. Clin Cancer Res. 2020;26:4643–50.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jang BS, Cha MJ, Kim HJ, Oh S, Wu HG, Kim E, et al. Heart substructural dosimetric parameters and risk of cardiac events after definitive chemoradiotherapy for stage III non-small cell lung cancer. Radiother Oncol. 2020;152:126–32. https://doi.org/10.1016/J.RADONC.2020.09.050

Article  PubMed  CAS  Google Scholar 

Vivekanandan S, Fenwick JD, Counsell N, Panakis N, Stuart R, Higgins GS, et al. Associations between cardiac irradiation and survival in patients with non-small cell lung cancer: Validation and new discoveries in an independent dataset. Radiother Oncol. 2021;165:119–25. https://doi.org/10.1016/J.RADONC.2021.10.016

Article  PubMed  Google Scholar 

Shepherd AF, Yu AF, Iocolano M, Leeman JE, Wild AT, Imber BS, et al. Increasing heart dose reduces overall survival in patients undergoing postoperative radiation therapy for NSCLC. JTO Clin Res Rep. 2021;2:100209. https://doi.org/10.1016/j.jtocrr.2021.100209

Article  PubMed  PubMed Central  Google Scholar 

Xu T, Meng QH, Gilchrist SC, Lin SH, Lin R, Xu T, et al. Clinical investigation assessment of prognostic value of high-sensitivity cardiac troponin t for early prediction of chemoradiation therapy-induced cardiotoxicity in patients with non-small cell lung cancer: a secondary analysis of a prospective randomized trial. Int J Radiation Oncol Biol Phys. 2021;111:2021. https://doi.org/10.1016/j.ijrobp.2021.07.035

Article  Google Scholar 

Atkins KM, Chaunzwa TL, Lamba N, Bitterman DS, Rawal B, Bredfeldt J, et al. Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non-small cell lung cancer. JAMA Oncol. 2021;7:206–19. https://doi.org/10.1001/jamaoncol.2020.6332

Article  PubMed  Google Scholar 

Niska JR, Hu J, Li J, Herman MG, Thorpe CS, Schild SE, et al. Using novel statistical techniques to accurately determine the predictive dose range in a study of overall survival after definitive radiotherapy for stage iii non-small cell lung cancer in association with heart dose. J Cancer Ther. 2021;12:505. https://doi.org/10.4236/JCT.2021.129044